QUÉBEC CITY, Nov. 21, 2011 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the "Company") today announced that it will be presenting a Company overview at the two following healthcare conferences in New York City:
23rd Annual Piper Jaffray Health Care Conference
Wednesday, November 30, 2011 at 12:30 p.m. (eastern)
New York Palace Hotel, New York City
Oppenheimer 22nd Annual Healthcare Conference
Tuesday, December 13, 2011 at 2:10 p.m. (eastern)
West Foyer Room, Waldorf-Astoria Hotel, New York City
A live webcast of the Oppenheimer Healthcare Conference presentation will be available on Aeterna Zentaris' website at www.aezsinc.com, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.
About Aeterna Zentaris Inc.
Aeterna Zentaris is a late-stage oncology drug development company
currently investigating potential treatments for various cancers
including colorectal, multiple myeloma, endometrial, ovarian, prostate
and bladder cancer. The Company's innovative approach of "personalized
medicine" means tailoring treatments to a patient's specific condition
and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn
from its proprietary discovery unit providing the Company with constant
and long-term access to state-of-the-art therapeutic options. For more
information please visit www.aezsinc.com
SOURCE AETERNA ZENTARIS INC.
